ConductScience.org, home

Gene · 8013

Papers2,089

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
The NOR-1/SPP1/OPN axis as a driver of abdominal aortic aneurysm.Transl Res202642790627PubTator, text miningPubMed
Impact of NR4A3 on wound healing in chronic venous ulcers and its association with the PI3K/Akt signaling pathway.Front Physiol202642741625PubTator, text miningPubMed
NOR1 loss relates to inflammation and biological ageing in multiple sclerosis motor cortex.Brain Commun202642661990PubTator, text miningPubMed
Adaptive proteomic remodeling and eNOS upregulation in luminal endothelium and perivascular adipose tissue of patent saphenous vein grafts after CABG.Cardiovasc Pathol202642594976PubTator, text miningPubMed
Long non-coding RNA SNHG6 promotes the proliferation of PASMCs cells through the miR-429/DUSP1 axis during early/subacute vascular responses to pulmonary embolism.Mol Cell Biochem202642550429PubTator, text miningPubMed
NOR-1 as a Context-Dependent Rheostat of Vascular and Cardiac Remodeling.FASEB J202642522710PubTator, text miningPubMed
Myoepithelioma-like tumor of the vulvar region shows a quiet genome and heterogeneous detectable mechanisms of SMARCB1 inactivation: Integrated analysis of two cases and review of the literature.Ann Diagn Pathol202642391872PubTator, text miningPubMed
[Early transcriptomic features of neutrophils and monocytes activated by the outer membrane protein MSP2 of anaplasma phagocytophilum].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi202642350344PubTator, text miningPubMed
Differential Expression Profiles of Orphan Nuclear Receptors (NR4A) and N-myc Downstream-Regulated Gene Family (NDRG) in Patients with Inflammatory Bowel Disease.Int J Mol Sci202642278299PubTator, text miningPubMed
Multimodal integration of neuroimaging, transcriptomics and single-cell analysis reveals molecular correlates linking osteoporosis to brain abnormalities.Front Immunol202642233024PubTator, text miningPubMed
Salivary gland carcinomas with BRAF fusions - an exceedingly rare and yet poorly characterized group of tumors, with potentially targetable molecular alteration.Virchows Arch202642168621PubTator, text miningPubMed
Nanoencapsulated Melaleuca leucadendra essential oil: improved antifungal efficacy against the storage fungi and aflatoxin B1 contamination.Food Sci Biotechnol202642077783PubTator, text miningPubMed
Myoepithelioma-like tumor of the vulvar region with estrogen receptor negativity and GSTT1::IGLC7 fusion: a case report.Front Oncol202642052495PubTator, text miningPubMed
Methylation and expression dynamics in broiler liver following in-ovo sodium butyrate administration.J Vet Res202641953747PubTator, text miningPubMed
Advanced microfluidic and 3D cell culture platforms for modeling vascularization in diabetic foot ulcers: A systematic review of translational challenges and perspectives.PLoS One202641941538PubTator, text miningPubMed
Extracellular Vesicle-Mediated Nucleolin Transfer in Glioblastoma: A Targetable Axis Driving Blood-Tumour Barrier Formation.J Extracell Vesicles202641926335PubTator, text miningPubMed
Differential microRNA expression profiles and predicted miRNA-mRNA regulatory networks in human macrophage-like cells infected with Leishmania infantum.Sci Rep202641888357PubTator, text miningPubMed
The acinar variant of poroma: a series of 3 cases with YAP1::NR4A3 fusion.Virchows Arch202641870614PubTator, text miningPubMed
Resistance-based exercise restores muscle health in dialysis patients.J Muscle Res Cell Motil202641831133PubTator, text miningPubMed
Smooth muscle NR4A3 upregulation caused by endothelial Caveolin-1 deficiency mediates vascular remodeling and pulmonary hypertension.Free Radic Biol Med202641812836PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/8013/papers